In what year was ritonavir approved for marketing by the FDA?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Drug Action 2 Exam. Focus on multiple-choice questions, learn through interactive quizzes, and understand core drug mechanisms with explanations. Dive deep into pharmacokinetics and pharmacodynamics to ace your test!

Multiple Choice

In what year was ritonavir approved for marketing by the FDA?

Explanation:
Ritonavir was approved by the FDA in 1996. It entered HIV therapy as one of the early protease inhibitors, helping to block the viral protease and slow the progression of infection. Later, its strong inhibition of the enzyme CYP3A4 allowed it to boost the levels of other protease inhibitors, enabling lower doses and more effective combination regimens. The other years listed don’t match the actual approval date, which places ritonavir’s debut in the mid-1990s.

Ritonavir was approved by the FDA in 1996. It entered HIV therapy as one of the early protease inhibitors, helping to block the viral protease and slow the progression of infection. Later, its strong inhibition of the enzyme CYP3A4 allowed it to boost the levels of other protease inhibitors, enabling lower doses and more effective combination regimens. The other years listed don’t match the actual approval date, which places ritonavir’s debut in the mid-1990s.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy